Antihypertensive Drugs: Vasodilators

Minoxidil is a prodrug metabolized by hepatic sulfotransferase into minoxidil sulfate, its active form. This metabolite activates ATP-sensitive potassium channels on smooth muscle cell membranes, allowing potassium ions to flow out and hyperpolarize the cell. Hyperpolarization closes voltage-gated calcium channels, reducing calcium influx and causing smooth muscle relaxation, which dilates blood vessels and lowers blood pressure.

Sodium nitroprusside releases nitric oxide, which activates soluble guanylyl cyclase in smooth muscle cells. This enzyme converts GTP to cyclic guanosine monophosphate (cGMP), activating protein kinase G. PKG opens potassium channels, inhibits calcium influx, and activates myosin light chain phosphatase. These combined actions reduce intracellular calcium and dephosphorylate myosin light chains, causing vasorelaxation and blood pressure reduction.

Oral vasodilators like minoxidil primarily target arteries and arterioles, while sodium nitroprusside acts on both arterioles and venules. By dilating these smaller vessels, vasodilators reduce peripheral resistance and lower blood pressure. This selective targeting of arterial and venous smooth muscle makes vasodilators effective for managing hypertension in various clinical settings.

Sodium nitroprusside is administered parenterally and acts rapidly on arterioles and venules to produce immediate vasorelaxation. Its fast onset makes it ideal for hypertensive emergencies requiring urgent blood pressure reduction. However, sodium nitroprusside releases cyanide during metabolism, posing a risk of cyanide poisoning with prolonged use, requiring careful monitoring.

When potassium ions flow out of smooth muscle cells, the cell membrane becomes hyperpolarized, or more negatively charged. This hyperpolarization closes voltage-gated calcium channels, preventing calcium ions from entering the cell. With reduced intracellular calcium, the muscle cannot contract, resulting in smooth muscle relaxation and blood vessel dilation.

Protein kinase G is activated by elevated cyclic guanosine monophosphate (cGMP) levels following nitric oxide signaling. Activated PKG opens potassium channels and inhibits calcium ion influx, lowering intracellular calcium. PKG also activates myosin light chain phosphatase, which dephosphorylates myosin light chains and prevents actin-myosin interaction, promoting smooth muscle relaxation.

Minoxidil is administered orally and primarily targets arteries and arterioles, while sodium nitroprusside is given parenterally and acts on both arterioles and venules. Minoxidil requires hepatic metabolism to become active, whereas sodium nitroprusside acts immediately upon release of nitric oxide. These differences make minoxidil suitable for chronic hypertension management and sodium nitroprusside ideal for acute emergencies.